Niagen Bioscience, Inc. · NASDAQ:NAGE
Fried Robert N exercised options for 20,000 Niagen Bioscience, Inc. shares (Form 4)
Traded Apr 24, 2026 · Filed Apr 27, 2026
On Apr 24, 2026, Fried Robert N (Director, Chief Executive Officer) exercised options for 20,000 Niagen Bioscience, Inc. shares at US$2.61 for US$52,200, leaving 1,058,981 shares. Filed Apr 27, 2026 (Form 4).
- Options exercised
- 20,000 shares
- Price
- US$2.61
- Value
- US$52,200
- Holding after
- 1,058,981 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 24, 2026 | Common Stock | Option exercise | 20,000 | US$2.61 | 1,058,981 | Direct |
Source
Related
- Niagen Bioscience, Inc.
- Fried Robert N
- Niagen Bioscience, Inc. shareholders
- Form 4 · Fried Robert N · Jul 8, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Form 4 · Lopez Carlos Luis · Jul 8, 2026
- Form 4 · Pamir Ozan · Jul 8, 2026
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G · The Vanguard Group · Oct 31, 2025